HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Protozoa Bioassay Is Promising Alternative To Animal Testing Of Mascara

This article was originally published in The Rose Sheet

Executive Summary

Using protozoa instead of rabbits and other animals to test mascara for acute toxicity could be a viable and relatively inexpensive strategy for cosmetics firms, according to researchers at the University of Liverpool, who published a related study recently in the International Journal of Cosmetic Science.

You may also be interested in...



U.S. Next Target In Cruelty Free’s Crusade For Global Animal-Test Ban

Cruelty Free International calls on FDA to follow the EU’s example and ban animal testing for cosmetic products and ingredients. The group has launched a new campaign to generate support among American consumers while inviting visitors to its website to sign a global pledge to end cosmetic animal testing worldwide.

EU Animal-Test Ban Exceptions Offer Wiggle Room – Cosmetics Europe

Firms using multipurpose ingredients that required animal testing to comply with non-cosmetics-related regulations are safe under the EU’s animal-testing ban, suggests Gerald Renner, Cosmetics Europe’s director of technical regulatory affairs, at the in-cosmetics conference in Paris. However, it appears that animal testing to fulfill requirements in third countries, such as China, can not be applied toward compliance with European law.

China Regulatory Probe Slows Nu Skin Growth After Record Year

The firm’s recent explosive growth is expected to slow substantially in the first quarter – to between 20% and 24% – but Nu Skin is confident the steps it is taking in China “make our long-term success more likely.” Analysts have faith in the firm as it works with Chinese officials to resolve an investigation into its business practices.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019131

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel